20 years of data suggest that ablation is a valid treatment option
Knocking out, then restoring, the immune system holds great promise
Molecular study suggests an update to AJCC guidelines
Capecitabine-based approach shows promise in a population with few options
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
CHIP Clinic's goals: Research, preventive care
Study combines hormonal therapy with prostatectomy and radiation therapy of bone lesions
Cleveland Clinic surgeons remove first brain tumor with Myriad NOVUS tool
Clinical trial investigates nerve-sparing approach
Study suggests limited role for CET in this cancer type
Multidisciplinary collaboration enables first such operation in a patient with MYH9 mutation
Advertisement
Advertisement